Submission date
21/06/2008
Registration date
12/09/2008
Last edited
12/09/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Retrospectively registered
? Protocol not yet added
? SAP not yet added
? Results not yet added and study completed for more than 1 year
? Raw data not yet added
Study completed

Plain English Summary

Not provided at time of registration

Study website

Contact information

Type

Scientific

Contact name

Dr Eduardo Schiffer

ORCID ID

Contact details

Hopitaux Universitaires de Geneve
24 Micheli-du-Crest
Geneva
1211
Switzerland

Additional identifiers

EudraCT/CTIS number

IRAS number

ClinicalTrials.gov number

Protocol/serial number

CER 03-159; SHR 369-08

Study information

Scientific title

Renal function during the perioperative period of liver transplantation

Acronym

Study hypothesis

Hyperreninism is the major mediator of transient and acute anuria during the anhepatic phase of liver transplantation.

Ethics approval(s)

Ethics Committee of the Geneva University Hospitals (Commission central d'éthique de la recherche sur l'être humain des HUG). Date of approval: 24/01/2004 (ref: CER 03-159)

Study design

Observational, prospective, cross-sectional study

Primary study design

Observational

Secondary study design

Cross-section survey

Study setting(s)

Hospital

Study type

Treatment

Patient information sheet

Condition

Liver transplantation

Intervention

Observational study: Blood sampling for biologic assessment of renal function at the time of inclusion in the waiting list, at the time of anaesthesia induction on the day of liver transplantation, during the anhepatic phase, 24 hours later and finally at 6 months.

Intervention type

Other

Primary outcome measure

Renal function: plasma renin activity, assessed in all blood samples (see Interventions).

Secondary outcome measures

The following were assessed in all blood samples (see Interventions):
1. Cystatin C
2. Natraemia

Overall study start date

01/08/2004

Overall study end date

01/01/2008

Reason abandoned (if study stopped)

Eligibility

Participant inclusion criteria

1. Both males and females
2. Age 17-70 years
3. Patients scheduled for liver transplantation

Participant type(s)

Patient

Age group

Adult

Sex

Both

Target number of participants

30

Participant exclusion criteria

Incapacity to comprehend the study protocol

Recruitment start date

01/08/2004

Recruitment end date

01/01/2008

Locations

Countries of recruitment

Switzerland

Study participating centre

Hopitaux Universitaires de Geneve
Geneva
1211
Switzerland

Sponsor information

Organisation

Geneva University Hospitals (Hôpitaux Universitaires de Genève) (Switzerland)

Sponsor details

24 Micheli du Crest
Geneva
1211
Switzerland

Sponsor type

Hospital/treatment centre

Website

http://www.hug-ge.ch

ROR

https://ror.org/01m1pv723

Funders

Funder type

Hospital/treatment centre

Funder name

Geneva University Hospitals (Hôpitaux Universitaires de Genève) (Switzerland)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Individual participant data (IPD) sharing plan

IPD sharing plan summary

Not provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?

Additional files

Editorial Notes